Neurocrine Biosciences, Inc. · NASDAQ:NBIX

Gano Kyle received 8,117 Neurocrine Biosciences, Inc. shares as an award (Form 4)

Traded Sep 11, 2026 · Filed Sep 15, 2026

On Sep 11, 2026, Gano Kyle (Director, Chief Executive Officer) received 8,117 Neurocrine Biosciences, Inc. shares as an award, leaving 154,728 shares. Filed Sep 15, 2026 (Form 4).

Awarded
8,117 shares
Holding after
154,728 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 11, 2026Common StockAward6,275157,266Direct
Sep 11, 2026Common StockShares withheld for tax3,386US$156.22153,880Direct
Sep 11, 2026Common StockAward1,842155,722Direct
Sep 11, 2026Common StockShares withheld for tax994US$156.22154,728Direct

Source

View original at SEC

Related